I am a Board Certified Pathologist in Anatomic and Clinical Pathology, with expertise in genitourinary pathology and interest in molecular genomics and soft tissue pathology. My research endeavors revolve around the development and validation ...
Read More
We are interested in the chemical biology of metabolism as a mediator of the host-pathogen interaction. We focus specifically on Mycobacterium tuberculosis and its ability to both asymptomatically infect and cause disease in humans.
The goal of Dr. Salmon’s research is to identify predictors and determinants of disease phenotype in systemic lupus erythematosus (SLE) and related diseases, and to thereby identify targets for therapy. In SLE and other ...
Read More
My lab is currently focused on two areas of immunology, canine immune mediated disease and aging of the immune system. We are particularly interested in identifying mechanistic biomarkers to help improve, diagnosis, prognosis and ...
Read More
My laboratory has focused much of its recent activity on understanding the role of tumor-secreted exosomes in cancer metastasis (Nature Medicine, 2012; Nature Cell Biology, 2015; Nature, 2015; Cancer Cell, 2016). My lab’s current ...
Read More
Dr. Guarino is interested in the development of novel serologic assays for the diagnosis of infection with viral and bacterial pathogens in companion and production animals. Of particular interest is the diagnosis of commonly ...
Read More
My research can be grouped into 3 broad categories: i) defining the role of DNA damage response mechanisms (DDR) in tumorigenesis and chemosensitivity as a means to identify biomarkers and therapeutic targets, ii) repurposing ...
Read More
Clinical Trials: Novel hemostatic therapies for bleeding; novel immunosuppressive therapies for IMHA; interventional trials for sepsis management. Laboratory Research: Biomarkers in emergency and critical care, novel assays for diagnosis and management of hemorrhage and ...
Read More
I am currently interested in employing predictive approaches (primarily through integrated analyses of public genomic datasets) that can be applied to various topics in cancer. These topics include: a) prediction of molecular markers for ...
Read More
